Mengliu Yang | Metabolism | Best Researcher Award Posted on 30/10/202401/11/2024 by sciencefatherLeave a Comment on Mengliu Yang | Metabolism | Best Researcher Award Assoc prof Dr. Mengliu Yang | Metabolism | Best Researcher Award Global Recognition: Her participation in significant global conferences, such as EASD, indicates her recognition in the international research community and her commitment to disseminating her findings. Assoc Prof Dr. Mengliu Yang , Chongqing Medical University , China Profile Scopus OrcID 🌱EARLY ACADEMIC PURSUITS Dr. Mengliu Yang began her academic journey at Chongqing Medical University, where her passion for cellular signaling in metabolic diseases was sparked. She later advanced her expertise under the mentorship of Professor John Whitehead at The University of Queensland, earning her Ph.D. with a focus on central nervous system-peripheral metabolic interactions. These foundational years equipped Dr. Yang with a multidisciplinary perspective, crucial for her later work in metabolic disease mechanisms and regulatory pathways. đź’Ľ PROFESSIONAL ENDEAVORS As an Associate Professor at The Second Affiliated Hospital of Chongqing Medical University, Dr. Yang leads a highly skilled team dedicated to advancing metabolic disease research. Her professional endeavors are backed by prestigious grants, including support from the National Natural Science Foundation of China and the Novo Nordisk Talent Fund. Dr. Yang’s work stands out for its combination of clinical research, cellular biology, and real-world impact on disease management, particularly in areas affecting metabolic regulation and obesity. 🔬 CONTRIBUTIONS AND RESEARCH FOCUS Dr. Yang’s research is focused on the “gut-brain-liver” axis, where she has identified pivotal molecules like NUCB2/nesfatin-1 and zinc-α2-glycoprotein (ZAG) that influence insulin resistance and energy balance. Her team’s work also highlights the role of hypothalamic POMC and AgRP neurons in controlling central and peripheral metabolic processes, contributing to new treatment targets for conditions like Type 2 diabetes and obesity. With 23 high-impact publications in journals such as Nature Communications, EMBO Journal, and Diabetes Care, her findings are shaping the future of metabolic research. đź“š ACADEMIC CITES Dr. Yang’s research has garnered significant attention, reflected in her impressive citation metrics: Total Citations: 3,410 h-Index: 36 i10-Index: 63 These metrics underscore her work’s influence, particularly in understanding metabolic signaling pathways and advancing therapeutic options for metabolic disorders. 🌍 Impact and Influence Dr. Yang’s influence extends globally through her presentations at major conferences, such as the European Association for the Study of Diabetes (EASD), and her editorial roles at Frontiers in Endocrinology and Frontiers in Public Health. Her contributions to clinical guidelines have furthered the field’s understanding of central-peripheral metabolic regulation, earning her recognition and a “Rising Star” distinction from the Chinese American Diabetes Association (CADA). 🌟 Legacy and Future Contributions With three ongoing research projects and four completed, Dr. Yang’s work is paving the way for breakthroughs in metabolic disease treatment. Her ongoing patents are expected to bring new innovations to metabolic research and patient care. Dr. Yang’s collaborative work with esteemed colleagues like Oluf Borbye Pedersen from the University of Copenhagen and Chen Chen from the University of Queensland highlights her commitment to international research advancements. đź“„Publications AZGP1 in POMC neurons modulates energy homeostasis and metabolism through leptin-mediated STAT3 phosphorylation Authors: Qiu, S., Wu, Q., Wang, H., … Li, L., Yang, M. Journal: Nature Communications, 2024, 15(1), 3377 Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering Authors: Alharbi, M., Lai, A., Godbole, N., … Wu, S.Y., Salomon, C. Journal: International Journal of Cancer, 2024, 155(8), pp. 1510–1523 Empagliflozin rescues lifespan and liver senescence in naturally aged mice Authors: Long, J., Ren, Z., Duan, Y., … Luo, X., Liu, D. Journal: GeroScience, 2024, 46(5), pp. 4969–4986 Combined serum CTRP7 and CTRP15 levels as a novel biomarker for insulin resistance and type 2 diabetes mellitus Authors: Xue, S., Ling, J., Tian, M., … Yang, M., Yang, G. Journal: Heliyon, 2024, 10(9), e30029 Hypothalamic P62 (SQSTM1) regulates energy balance by modulating leptin signaling Authors: Yang, S., Li, Y., Tian, M., … Li, L., Yang, M. Journal: Theranostics, 2024, 14(17), pp. 6605–6624